Will the mRNA flu vaccine come into being?
At the end of November 2025, the New England Journal of Medicine published an article on a clinical trial of a messenger RNA vaccine against seasonal influenza. The article was written by researchers working for Pfizer, the company that developed the vaccine. Pfizer is keen to show that its vaccine is more effective than conventional vaccines. However, independent experts have pointed out major omissions and inconsistencies in the publication, which minimise or even call into question the trial’s conclusions.
Self-amplifying messenger RNA “vaccine”: after the human, the duck
A year and a half ago, France made it compulsory to vaccinate farmed ducks against the avian influenza virus, in order to protect its meat and foie gras industries. To date, France is the only country to have taken this vaccination route. One of the two vaccines used, the self-amplifying messenger RNA (mRNA) vaccine, raises questions.